Drug and herbal/dietary supplements-induced liver injury: A tertiary care center experience

Table 1 Clinical features of patients with DILI/HDS according to the histopathological pattern of injury

	Hepatocellular	Cholestatic	Mixed
n (%)	18 (49)	5 (14)	15 (39)
Age (mean ± SD)	50 ± 8	65 ± 5	49 ± 18
Gender (M:F)	5:13	3:2	7:8
Initial ALT (mean ± SD)	870 ± 280	37 ± 32	470 ± 190
Initial AST (mean ± SD)	780 ± 110	44 ± 54	360 ± 600
Initial ALP (mean ± SD)	190 ± 93	300 ± 25	220 ± 91
R ratio (mean ± SD)	12 ± 0.4	0.5 ± 0.1	6.4 ± 0.9
Total bilirubin (mean ± SD)	5.5 ± 0.4	4.3 ± 4.5	3.7 ± 1.5
Platelet count/µL (mean ± SD)	230000 ± 92000	230000 ± 130000	220000 ± 31000

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase.